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Rhabdomyosarcoma of the orbit in a four months old infant in
Zimbabwe: A case report
*1 CH ITSIK E, **R MASANC,ANISE, ***D SIBANDA, *P KEONA
A b s tra c t
Infants younger than one year o f  age with RhabdomyosaicoiiicT^appear to have worse prognosis com pared to 
older children due partly to high rates o f  local failure. We report a 4 m onths old infant w ith orbital 
rhabdom yosarcom a with poor outcom e.. Reluctance to use aggressive local control m easures and suboptim al 
chem otherapy dosing are significant contributory factors. Call is m ade for need for m ore studies to determ ine 
appropriate local therapy in infants with rhabdom yosarcom a.
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Introduction
Rhabdomyosarcoma is known to be the commonest 
primary paediatric orbital malignancy seen in the 
developed countries to date. It is widely accepted that 
the tumour arises independently of the muscles and 
probably develops from undifferentiated mesenchymal 
cells in the orbit, conjunctiva, eyelid or anterior uveal 
tract. Rhabdomyosarcoma (RMS) has an incidence of 
about 5% among orbital biopsies of children and 
adolescents, the orbit being the primary site of origin in 
10% of cases and the average age of onset being 5 to 7 
years of age. The tumour is more aggressive and carries 
a poorer prognosis in infancy. Clinically 80 to 100% of 
patients present with proptosis. 80% with globe 
displacement, 30 to 50% with blcpharoptosis. 60% 
with conjunctival and eyelid swelling, 25% with 
palpable mass, while 10% present with pain. 
Histologically there are three types: the embryonal cell 
type being the commonest and has a good prognosis 
(94% 5-year survival rate), the alveolar cell type is the 
second in frequency but has a poorer prognosis (74% 5- 
year survival rate) and the botryoid cell type that rarely 
occurs in the orbit.1'
Case Report
A 4 months old baby girl presented to Sekuru Kaguvi 
Hospital Eye Unit with a history o f swelling of the right 
eye dating from 2 months of age. The mother initially 
noticed redness of the eye followed by swelling and
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protrusion of the globe. She was seen by the 
ophthalmologist who noted that the right eye had axial 
proptosis measuring 34mm (using a transparent ruler). 
The proptosis was slightly deviated medially. It was 
non-reducible. There was conjunctival injection and 
chemosis. There was exposure keratopathy with a 
melted cornea inferiorly and a descematocele 
superiorly. Anterior segment structures were not 
visible. The eyelids were normal but there was 
widening of palpebral fissure height. An orbital mass 
was palpable infero-temporally. The mass was soft, 
non-tender, non-pulsatile and without bruits on 
auscultation. The left eye was otherw ise normal. There 
was no parotid or sub-mental lymphadenopathy. A 
working diagnosis o f a right retinoblastoma with extra 
orbital extensions was suggested. The differential list 
included rhabdom yosarcom a, lym phom a, and 
neuroblastoma. The patient was then referred to the 
paediatric oncology unit for further management.
On general examination in the paediatric oncology 
unit the marked proptosis of the right eye was noted as 
shown in figure 1. The growth o f the infant was within 
normal range with a weight of 5.6kg (10-50"' centile), 
length 62cm (50"' centile) and head circumference 
41,5cm (50-90"' centile). Examination of the rest o f the 
systems revealed an opisthotonic baby with right upper 
facial nerve palsy, generalized hypertonia and 
increased reflexes. The abdomen was distended with a 
4cm hepatomegaly. The remainder of the physical 
examination was unremarkable. There was no
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evidence of distant metastatic disease. Laboratory 
investigations showed normal full blood count and 
biochemical values.
Figure I: Picture showing marked proptosis o f  the 
right eye.
Figure II: C T sc an right or bit and brain.
A CT scan of the brain revealed the following findings: 
“Large right lobulated intra orbital retro-bulbar mass
extending into the middle cranial fossa that was hyper- 
dense and enhanced following contrast infusion. The 
mass incorporated the optic nerve, right side o f optic 
chiasm and right cavernous sinus. There was no 
associated bony erosion or th ickening” . The 
differentials suggested by the radiologist included 
optic nerve glioma and lymphoma.
The lesion was biopsied for histology and initially 
reported as: “Sections show conjunctiva with an 
underlying lesion comprised o f small cells with scanty 
cy top lasm  and h y p erch ro m a tic  nuc le i. The 
appearances are consisten t w ith Em broyonal 
R habdom yosarcom a” it w as suggested  that 
immunohistochemistry would be helpful. Part o f the 
biopsied tissue was sent to St Jude Children's Research 
Hospital for immunohistochemistry that is not locally 
available. Immunohistochemistry confirmed rhabdoid 
tumour although it was not possible to decide whether 
the tumour originated in the middle cranial fossa and 
brain with extension into the orbit or vice versa, hence 
the suggestion o f a possible atypical teratoid-rhabdoid 
tumour. However, both tumours are identical except for 
their sites o f origin.
Treatm ent
The main stay o f treatment in this patient was 
chemotherapy. The patient received vincristine, 
dactinomycin and ifosfamide the dosages calculated by 
weight and body surface area depending on the 
chemotherapeutic agent. The patient was given 50% of 
the prescribed chemotherapy doses at the initial phase 
as recommended for that age.4 5 Radiotherapy was not 
used in this patient because of her age and location of 
tumour. Surgical intervention was not employed in our 
case because of intracranial involvement that carried a 
very poor surgical outcome and as recommended in 
other studies.6 7
Follow up
The patient responded well to 2 cycles o f 
chemotherapy given at 3 weeks interval. The swelling 
began to subside initially but by the third cycle the size 
o f the tumour was increasing with evidence o f local 
disease progression but with no distant metastasis on 
clinical examination. At that stage a decision not to 
proceed with chemotherapy but offer palliative care 
was made.
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XFigure III: Picture showing local progression o f  
disease six weeks after commencing chemotherapy.
Discussion
Published literature show that the incidence of 
rhabdomyosarcoma (RMS) is higher during the first 
year o f life.8,9 Our patient was four months old when the 
diagnosis was made and could be the youngest case 
with this disease to be reported in Zimbabwe. This 
young age of presentation is uncommon for Zimbabwe 
although from the literature it appears young age of 
presentation is not unusual.1012 In a series o f 33 South 
African children with RMS, Schyff and colleague 
reported the youngest age to be 7 days old.”
In Zimbabwe a total o f 102 children under the age of 
15 years with RMS were registered with the Zimbabwe 
National Cancer Registry between 2000 and 2009. The 
male to female ratio was 1.7:1. A total o f 48 were not 
classified. O f those classified, embroyonal rhabdo was 
the commonest classification with 38 cases, followed 
by alveolar 14 cases and pleomorphic only 2 cases.14
K now n p rognostic  facto rs associa ted  w ith 
unfavourable outcome include young age at onset, 
alveolar / undifferentiated tumour and advanced group 
and stage o f tumour on assessment. Joshi and 
colleagues confirmed that age at presentation was an 
independent prognostic factor after adjusting for 
important prognostic factors. They also showed tha - 
patients less than one year of age at diagnosis wer< 
associated with worse outcome.15
However, this finding has not been supported by other 
researchers who in a study of 78 patients younger than 
one year, did not find age to be an important prognostic 
determinant o f outcome in rhabdomyosarcoma.11
Histopathology.
The histopathology in our case was embroyonal 
rhabdomyosarcoma. This is in line with the findings in 
the Zimbabwe National Cancer Register where 
embryonic RMS was the commonest histological type
reported.14 This finding is similar to that by the 
Children's Oncology Group where embryonal 
rhabdomyosarcoma was the commonest histological 
type ( 57%) in their group of children less than one 
year age.5 Other studies however have shown different 
results. Ragab et al reported significantly higher 
proportions o f undifferentiated sarcoma and botryoid 
pathology.10 Salloum et al found higher frequency of 
alveolar and poorly differentiated histologic subtypes 
in infants aged under one year.11
Treatment received and outcome
The treatment of RMS in infants is a challenge. A lot 
depends on patient age, accurate patient evaluation, 
stage and severity o f disease. Our patient was four 
months old, with RMS involving the orbit with 
intracranial extensions and no clinically significant 
lymphadenopathy. Local disease control in terms of 
surgical excision was not undertaken because o f the 
likelihood of poor surgical outcome and as advocated 
by Heyn et al.16 Radiotherapy was not given in our 
patient because of the patient's age and extent of 
intracranial involvem ent.17 Our patient received 
multiple-agent therapy but the choice o f drugs was 
severely compromised by drug availability.
In addition to that our patient received 50% of 
chemotherapy dose recommended for older children. 
This is in line with recommendations from the IRS 
protocol which was amended so that infants would 
receive only 50% of recommended dose for older 
children in order to mitigate the toxic effects of 
chemotherapeutic agents on infants.5 This low dosage, 
probably suboptimal treatment could also have 
contributed to poor outcome in our patient.
Researchers from the Children's Oncology Group 
have concluded that reluctance to use aggressive local 
control measures because o f concerns regarding 
morbidity in infants may lead to high failure rate.16 
There are now calls to review the management o f these 
patients in order to improve the outcome in infants.5 
Findings from Puri et al suggest that appropriate 
radiotherapy in very young children can be 
administered to achieve reasonable local control.17 
However, for resource challenged countries the 
problems of drug availability outweigh the dilemmas 
o f choosing the most appropriate treatment protocol, as 
is the case locally.
Conclusion
in conclusion, we report a case of RMS in a 4 months 
old, youngest reported case in Zimbabwe who 
presented with aggressive disease and failed on 
treatment. Our patient had some poor prognostic 
factors that could explain the poor outcome, the young 
age at presentation, inadequate treatment for local 
control such as surgery and radiotherapy and probably 
suboptimal chemotherapy dosing. It is essential that 
studies are carried out to determine appropriate local
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therapy particularly use of radiotherapy in infants and 
pharmacokinetic studies for optimum chemotherapy 
dosing.
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